HIL Applied Medical CEO Sagi Brink-Danan explains the potential to make proton therapy more accessible to eligible cancer patients explained.

HIL Applied Medical CEO Sagi Brink-Danan explains the potential to make proton therapy more accessible to eligible cancer patients explained.